$CLSD Clearside Biomedical, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Clearside Biomedical, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Clearside Biomedical, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Clearside Biomedical, Inc. for free.
IRS Number: 452437375
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: CLSD
Company Address: 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 30005
Phone number: 678-270-3631
Market Capitalization: $146.03M
Prev close: $7.25
Average Daily Volume: 244,006
Days Low: $7.05
Year Low: $5.65
Year High: $25.08
Clearside Biomedical, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11 2021 | CLSD | Clearside Biomedic ... | Hutson Nancy J | Director | Option Exercise | A | 3.11 | 25,000 | 77,750 | 25,000 | |
| Jun 11 2021 | CLSD | Clearside Biomedic ... | EDWARDS JEFFREY L | Director | Option Exercise | A | 3.11 | 25,000 | 77,750 | 25,000 | |
| Jun 11 2021 | CLSD | Clearside Biomedic ... | Humphries William D. | Director | Option Exercise | A | 3.11 | 25,000 | 77,750 | 25,000 | |
| Jun 11 2021 | CLSD | Clearside Biomedic ... | SHAFFER CHRISTY L | Director | Option Exercise | A | 3.11 | 25,000 | 77,750 | 25,000 | |
| Mar 23 2021 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | CEO | Sell | S | 2.82 | 3,370 | 9,503 | 430,239 | 433.6 K to 430.2 K (-0.78 %) |
| Mar 15 2021 | CLSD | Clearside Biomedic ... | Hutson Nancy J | Director | Buy | P | 3.11 | 5,000 | 15,525 | 10,000 | 5 K to 10 K (+100.00 %) |
| Mar 15 2021 | CLSD | Clearside Biomedic ... | Hutson Nancy J | Director | Buy | P | 3.11 | 5,000 | 15,525 | 10,000 | 5 K to 10 K (+100.00 %) |
| Feb 12 2021 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 4.43 | 32,873 | 145,627 | 3,433,521 | 3.5 M to 3.4 M (-0.95 %) |
| Jan 20 2021 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | CEO | Option Exercise | A | 4.01 | 284,750 | 1,141,848 | 284,750 | |
| Jan 20 2021 | CLSD | Clearside Biomedic ... | LASEZKAY GEORGE M | CEO | Grant | A | 0.00 | 140,250 | 0 | 439,609 | 299.4 K to 439.6 K (+46.85 %) |
| Jan 20 2021 | CLSD | Clearside Biomedic ... | Deignan Charles A. | Chief Financial Off ... | Option Exercise | A | 4.01 | 195,640 | 784,516 | 195,640 | |
| Jan 20 2021 | CLSD | Clearside Biomedic ... | Deignan Charles A. | Chief Financial Off ... | Grant | A | 0.00 | 96,360 | 0 | 322,187 | 225.8 K to 322.2 K (+42.67 %) |
| Jan 20 2021 | CLSD | Clearside Biomedic ... | Ciulla Thomas | Chief Medical Offic ... | Option Exercise | A | 4.01 | 209,375 | 839,594 | 209,375 | |
| Jan 20 2021 | CLSD | Clearside Biomedic ... | Ciulla Thomas | Chief Medical Offic ... | Grant | A | 0.00 | 103,125 | 0 | 253,122 | 150 K to 253.1 K (+68.75 %) |
| Jan 07 2021 | CLSD | Clearside Biomedic ... | WHITMORE BRADFORD T | 10% Owner | Buy | P | 2.85 | 350,750 | 999,988 | 3,529,845 | 3.2 M to 3.5 M (+11.03 %) |